0001415889-24-006685.txt : 20240305 0001415889-24-006685.hdr.sgml : 20240305 20240305163258 ACCESSION NUMBER: 0001415889-24-006685 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YOUNG TODD S. CENTRAL INDEX KEY: 0001682584 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 24721176 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 3611 VALLEY CENTRE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825497352 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 4 1 form4-03052024_090309.xml X0508 4 2024-03-01 0001739104 Elanco Animal Health Inc ELAN 0001682584 YOUNG TODD S. C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 false true false false SEE REMARKS 0 Common Stock 2024-03-01 4 A 0 43903 0 A 152176 D Common Stock 2024-03-01 4 F 0 14000 16.03 D 138176 D Common Stock 2024-03-05 4 G 0 37999 0 D 100177 D Common Stock 2024-03-05 4 G 0 37999 0 A 152308 I By Living Trust Common Stock 2024-03-05 4 G 0 1500 0 D 150808 I By Living Trust Common Stock 2024-03-05 4 G 0 1500 0 A 3500 I As UTMA custodian for daughter Common Stock 2024-03-05 4 G 0 1500 0 D 149308 I By Living Trust Common Stock 2024-03-05 4 G 0 1500 0 A 3500 I As UTMA custodian for son Common Stock 6562 I By IRA Common Stock 2000 I By J. G. Young IRA Employee Stock Option(right to buy) 16.03 2024-03-01 4 A 0 95749 0 A 2034-03-01 Common Stock 95749 95749 D Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027. Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. On March 5, 2024, the reporting person transferred 37,999 directly owned shares to a living trust, of which the insider and his spouse are trustees and beneficiaries. Reflects a transfer to the reporting person as custodian for daughter under Uniform Gift to Minors Act. Reflects a transfer to the reporting person as custodian for son under Uniform Gift to Minors Act. Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027. Executive Vice President and Chief Financial Officer /s/ Amy C. Seidel, as Attorney-in-Fact for Todd S. Young 2024-03-05